Paris, France

Andreas Karlsson

This inventor holds 5 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Sanofi, Sanofi Pasteur Inc., Sanofi-Aventis. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Karlsson. Retrieved from https://idiyas.com/inventor/andreas-karlsson-yf40mzlx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5 

% Patents Active = 40.0

 

Average Co-Inventor Count = 5.5

ph-index = 1


Company Filing History:


Years Active: 2011-2026

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Andreas Karlsson

Introduction

Andreas Karlsson, an inventive mind based in Paris, France, has made significant contributions to the field of therapeutics with his groundbreaking inventions. With two patents to his name, he is recognized for his innovative approaches towards chemical compounds that show promise in medicinal applications.

Latest Patents

Karlsson's latest patents include:

1. **1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives**. This invention encompasses derivatives of 1-oxo-isoindoline-4-carboxamides and their therapeutic viability. The preparation and therapeutic uses of these compounds highlight their potential in advancing treatment methodologies.

2. **Derivatives of 1-OXO-1,2-dihydroisoquinoline-5-carboxamides and of 4-OXO-3,4-dihydroquinazoline-8-carboxamides**. This patent relates to the compounds of formula I, and also discusses their preparation and therapeutic applications, illustrating Karlsson's ongoing commitment to medicinal innovation.

Career Highlights

Throughout his career, Andreas Karlsson has been associated with notable companies such as Sanofi and Sanofi-Aventis. His experience in these pharmaceutical giants has undoubtedly influenced his research and development endeavors, allowing him to leverage industry resources to cultivate his inventive projects.

Collaborations

Collaborating with esteemed professionals, including Michel Evers and Arielle Genevois-Borella, has enhanced Karlsson's inventive processes. These collaborative efforts have fostered a dynamic exchange of ideas and expertise, contributing to the refinement of his inventions and their practical applications.

Conclusion

Andreas Karlsson stands out as an accomplished inventor in the realm of therapeutic innovations. His work not only showcases his inventive capabilities but also emphasizes the importance of collaboration and industry experience. With his patents pointing towards significant medicinal advances, Karlsson continues to embody the spirit of innovation in the pharmaceutical sciences.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…